| eradication |
151 |
| fibromyalgia syndrome |
151 |
| helicobacter pylori |
151 |
| tender point. |
151 |
| ankylosing spondylitis |
155 |
| difficult intubation |
155 |
| disease activity index |
155 |
| predictor |
155 |
| spinal mobility index. |
155 |
| grip ability test |
160 |
| hand disability |
160 |
| rheumatoid arthritis. |
160 |
| child |
167 |
| clinical manifestation |
167 |
| systemic lupus erythematosus. |
167, 228 |
| acute liver failure |
171 |
| autoimmune disease |
171, 194 |
| hepatitis b virus reactivation |
171 |
| immunomodulatory therapy. |
171 |
| hydroxychloroquine |
178 |
| retinotoxicity |
178 |
| spectral domain ocular coherence tomography. |
178 |
| extracorporeal shock wave therapy |
186 |
| myofascial pain syndrome |
186 |
| trigger point. |
186 |
| biologic therapy |
194 |
| inflammatory disorder |
194 |
| off-label |
194 |
| rituximab. |
194 |
| a disintegrin-like and metalloproteinase with thrombospondin motifs |
203 |
| apoptosis |
203 |
| hydrogen peroxide |
203 |
| hypericum perforatum |
203 |
| oums-27 |
203 |
| primary synovial chondromatosis |
215 |
| synovial chondrometaplasia |
215 |
| synovial osteochondromatosis. |
215 |
| childhood |
219 |
| juvenile systemic sclerosis |
219 |
| scleroderma. |
219 |
| carpal tunnel syndrome |
224 |
| myositis |
224 |
| polymyositis. |
224 |
| axilla |
228 |
| lipogranuloma |
228 |
| aortic valve |
232 |
| granulomatosis |
232 |
| mass |
232 |
| polyangiitis |
232 |
| vasculitis. |
232 |
